ArticleThe American journal of case reports2026
Exertional Rhabdomyolysis With Moderate Creatine Kinase Elevation and Marked Transaminase Elevation but Preserved Synthetic Function: A Case Report.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Rhabdomyolysis is a skeletal muscle injury syndrome characterized by release of intracellular contents into the circulation. Abnormal liver biochemical test results are commonly observed in severe rhabdomyolysis. Most published cases have focused on extreme creatine kinase (CK) elevations (often >30 000 U/L) complicated by fulminant hepatic failure. There is a lack of literature regarding instances in which marked transaminase elevation occurs despite moderate CK elevation. CASE REPORT A 43-year-old man exhibited fatigue, nausea, and myalgia after a 3000-m run. Laboratory tests showed moderate CK elevation but striking transaminase elevation. Peak values were: CK, 2828 U/L; aspartate aminotransferase (AST), 2294 U/L; alanine aminotransferase (ALT), 1554 U/L; AST/ALT ratio, 1.48. Total bilirubin peaked at 34.2 μmol/L, the international normalized ratio was 1.22, and albumin level remained normal. Viral hepatitis serology findings were negative. The patient was diagnosed with exertional rhabdomyolysis; treatment comprised intravenous fluids, urine alkalinization, and hepatoprotective agents. CK and transaminase levels rapidly declined. At discharge on day 8, the patient was asymptomatic (ALT, 339 U/L). At 1 week, ALT had decreased to 79 U/L; all laboratory parameters were normal at 1 year. CONCLUSIONS Exertional rhabdomyolysis can produce marked transaminase elevation despite moderate CK elevation, which may not be linearly correlated with AST and ALT levels. This case documents the unusual phenotype of marked transaminase elevation with preserved synthetic function in a patient showing moderate CK elevation. In selected patients with preserved synthetic function and rapidly declining enzyme levels, conservative management may be appropriate after alternative liver injury etiologies have been excluded.
Indexed as
Identifiers
42827313What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.